LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
28.62
+0.19 (0.67%)
Nov 5, 2024, 1:14 PM EST - Market open
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $786.95 million as of November 5, 2024. Its market cap has increased by 474.00% in one year.
Market Cap
786.95M
Enterprise Value
587.32M
1-Year Change
474.00%
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on June 25, 2021, LENZ Therapeutics's market cap has decreased from $951.31M to $786.95M, a decrease of -17.28%. That is a compound annual growth rate of -5.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 781.70M | 414.28% |
| Dec 29, 2023 | 152.00M | -21.28% |
| Dec 30, 2022 | 193.10M | -73.25% |
| Dec 31, 2021 | 721.90M | -24.12% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 783.08M |
| Nuvation Bio | 769.99M |
| Annexon | 769.16M |
| Erasca | 768.07M |
| Pacira BioSciences | 764.32M |
| Arbutus Biopharma | 747.58M |
| Oculis Holding AG | 746.41M |
| Standard BioTools | 738.60M |